Pre-market Hot Trades in US Stocks
Aimei Health Tech, up 8.33% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Top Gainers in Pre-market US Stocks
Can-Fite, up 47.70% in pre-market. Based on recent key news:
<ol>
<li>
On December 26, Can-Fite BioPharma announced that the Brazilian Patent Office granted it a patent related to A3 adenosine receptor agonists for the treatment of sexual dysfunction. This patent strengthens the company's global patent portfolio, driving the stock price up.
</li>
<li>
On December 24, the company's board approved a 1-for-3000 reverse stock split, resulting in a 29% drop in the stock price during after-hours trading. This split will take effect on January 5, 2026, affecting investor confidence.
</li>
<li>
On December 24, Can-Fite BioPharma disclosed its plan for a reverse split of its common stock, which will be implemented by the Tel-Aviv Stock Exchange on January 2, 2026, marking a significant change for the company's shareholders. The biotechnology sector has been quite volatile recently and requires attention.
</li>
</ol>
Northann, up 36.13% in pre-market. Based on recent key news:
<ol>
<li>
On December 23, Northann Corp. released an important announcement through the EDGAR system, possibly involving strategic adjustments or financial information updates, leading to a significant rise in stock price. Source: PUBT
</li>
<li>
On December 24, DBS analyst Pei Hwa Ho reiterated a buy rating on Northann Corp. with a target price of S$1.25, with analyst consensus being moderately buy, boosting market confidence. Source: TipRanks
</li>
<li>
On December 24, technical sentiment signals indicated a sell, yet the market still showed a positive reaction to Northann's stock price, with a trading volume of 173,507. Source: PUBT Market confidence in Northann has strengthened, and trading is active.
</li>
</ol>
PicoCELA, up 33.35% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

AFJK

Aimei Health Tech pre-market up 8.33%; Can-Fite BioPharma pre-market up 47.70%; Northann pre-market up 36.13%; PicoCELA pre-market up 33.35%

Pre-market hot trades in US stocks: Aimei Health Tech up 8.33% in pre-market, with active capital inflow attracting market attention